Protein-Based Vaccine May Protect Against Malaria

By studying **antibodies** in the blood of Amazonian natives living in malaria endemic areas, researchers have discovered promising new targets for a **malarial vaccine**. In Brazil, Plasmodium vivax was responsible for 80% of the 600,000 cases of malaria reported in 2005 and malaria-related morbidity across the Amazon Basin. Emerging resistance to the frontline antimalarial drug, chloroquine, is of major concern as the mutation of target antigens complicates the development of new preventative therapies. Whole article on "ScienceDaily":[ http://www.sciencedaily.com/releases/2007/10/071026172821.htm]

---